ASM Oral Presentation Australian Society for Microbiology Annual Scientific Meeting 2025

Investigation of microbial signatures associated with response to faecal microbiota transplantation in ulcerative colitis (121147)

Shreeya S Raich 1 , Marwan E Majzoub 1 , Craig Haifer 2 3 , Sudarshan Paramsothy 4 5 , Thomas J Borody 6 , Rupert W Leong 4 5 , Nadeem O Kaakoush 1
  1. School of Biomedical Sciences, Faculty of Medicine and Health, UNSW, Sydney, NSW 2052, Australia
  2. School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, NSW 2052, Australia
  3. Department of Gastroenterology, St Vincent’s Hospital, Sydney, NSW 2010, Australia
  4. Concord Clinical School, University of Sydney, Sydney, NSW 2006, Australia
  5. Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia
  6. Centre for Digestive Diseases, Sydney, NSW 2046, Australia
Publish consent withheld
  1. Haifer C, Paramsothy S, Kaakoush NO, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7:141-151.